RetinalGenix Technologies (RTGN) Amortizatization of Intangibles (2025 - 2026)
RetinalGenix Technologies recorded quarterly Amortizatization of Intangibles of $642.0 in Q1 2026, little changed quarter-over-quarter from $642.0 in Q4 2025, and little changed year-over-year from $641.0 in Q1 2025.
RetinalGenix Technologies' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $642.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.16% year-over-year to $642.0; the TTM figure through Mar 2026 stood at $2564.0 (changed N/A YoY), while the FY2025 annual figure was $2563.0, up 200.12% from the prior year.
- Amortizatization of Intangibles came in at $642.0 for Q1 2026 at RetinalGenix Technologies, roughly flat from $642.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $642.0 in Q4 2025 to a low of $640.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 75.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | RetinalGenix Technologies | - | - | - | 642.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 642.00 |
| Mar 31, 2026 | 642.00 |
| Dec 31, 2025 | 642.00 |
| Dec 31, 2025 | 642.00 |
| Sep 30, 2025 | 640.00 |
| Sep 30, 2025 | 640.00 |
| Jun 30, 2025 | 640.00 |
| Jun 30, 2025 | 640.00 |
| Mar 31, 2025 | 641.00 |
| Mar 31, 2025 | 641.00 |